Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Respiratory syncytial virus vaccine development.

J E Crowe1

  • 1Department of Pediatrics, Vanderbilt University Medical Center, D-7235 Medical Center North, 1161 21st Avenue South, Nashville, TN 37232-2581, USA. james.crowe@vanderbilt.edu

Vaccine
|October 6, 2001
PubMed
Summary

Developing a respiratory syncytial virus (RSV) vaccine for infants faces challenges with animal models and infant immunity. Recent progress includes live attenuated and subunit vaccine candidates in clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.

mBio·2015
Same author

Location and length distribution of somatic hypermutation-associated DNA insertions and deletions reveals regions of antibody structural plasticity.

Genes and immunity·2012
Same author

High-throughput antibody sequencing reveals genetic evidence of global regulation of the naïve and memory repertoires that extends across individuals.

Genes and immunity·2012
Same author

Surfing a genetic association interaction network to identify modulators of antibody response to smallpox vaccine.

Genes and immunity·2010
Same author

Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomes.

Bone marrow transplantation·2010
Same author

Integrated analysis of genetic and proteomic data identifies biomarkers associated with adverse events following smallpox vaccination.

Genes and immunity·2008

Area of Science:

  • Pediatrics
  • Vaccinology
  • Virology

Background:

  • Respiratory Syncytial Virus (RSV) is a major cause of infant respiratory illness.
  • Existing challenges include the lack of ideal animal models and infant immunological immaturity.
  • Previous vaccine development efforts have faced significant hurdles.

Purpose of the Study:

  • To review the obstacles in developing an effective RSV vaccine for infants.
  • To highlight recent advancements in RSV vaccine development.
  • To provide an overview of current vaccine candidates in clinical trials.

Main Methods:

  • Literature review of RSV vaccine development.
  • Analysis of challenges in animal modeling and infant immunization.
  • Summary of progress in live attenuated and protein subunit vaccine candidates.

Related Experiment Videos

Main Results:

  • Significant progress has been made in developing novel RSV vaccine candidates.
  • Live attenuated viruses and protein subunit approaches show promise.
  • Multiple RSV vaccine candidates are progressing through early clinical trials.

Conclusions:

  • Despite obstacles, advancements in RSV vaccine technology are notable.
  • Ongoing clinical trials are crucial for evaluating vaccine efficacy and safety.
  • The development of an infant RSV vaccine remains a critical public health goal.